SelectQuote, Inc. Form 8-K Summary
Business Context and Reporting Period
SelectQuote, Inc. filed this Current Report on February 7, 2023, reporting financial results for the second quarter ended December 31, 2022. The filing furnishes an earnings press release and investor presentation as Exhibits 99.1 and 99.2.
Financial Results and Key Metrics
The filing text provided does not include the earnings press release or investor presentation and therefore does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating metrics, or other financial results.
Material Changes Versus the Prior Comparable Period
The filing text does not provide sufficient financial data to assess changes from the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
- The Company referenced its notification to the New York Stock Exchange of its intent to cure a stock-price deficiency and any potential plans for doing so.
- Management’s ability to regain compliance with NYSE continued-listing standards within the applicable cure period is identified as a material uncertainty.
- The Company also cautioned that it must continue complying with applicable NYSE listing standards.
- Forward-looking statements are subject to risks and uncertainties described in the Company’s Form 10-K for the year ended June 30, 2022 and subsequent SEC filings.
- The earnings release and investor presentation were furnished under Items 2.02 and 7.01 and are not deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference, except where expressly stated.
Important Facts for Investors to Verify
- Review Exhibit 99.1 for the complete second-quarter financial results, comparative figures, non-GAAP measures, and any guidance.
- Review Exhibit 99.2 for management commentary, operating metrics, outlook, and liquidity information.
- Verify the status, cure deadline, and conditions associated with the NYSE stock-price deficiency.
- Review the Company’s Form 10-K risk factors and subsequent filings for additional listing, liquidity, operating, and financial risks.